Molecular virology

CDC worker in the maximum containment virology laboratory

Molecular virology is the study of viruses on a molecular level. Viruses are submicroscopic parasites that replicate inside host cells.[1][2] They are able to successfully infect and parasitize all kinds of life forms- from microorganisms to plants and animals- and as a result viruses have more biological diversity than the rest of the bacterial, plant, and animal kingdoms combined.[2][3] Studying this diversity is the key to a better understanding of how viruses interact with their hosts, replicate inside them, and cause diseases.[2]

Viral replication

Viruses rely on their host to replicate and multiply. This is because viruses are unable to go through cell division, as they are acellular–meaning they lack the genetic information that encode the necessary tools for protein synthesis or generation of metabolic energy; hence they rely on their host to replicate and multiply. Using the host cell's machinery the virus generates copies of its genome and produces new viruses for the survival of its kind and the infection of new hosts.The viral replication process varies depending on the virus's genome.[2]

Classification

In 1971 David Baltimore, a Nobel Prize-winning biologist, created a system called Baltimore Classification System.According to this system, viruses are classified into seven classes based on their replication strategy:[2][4]

Viral replication cycle - simplified

Replication cycle

Regardless of the differences among viral species, they all share six basic replication stages:[2][5]

Attachment is the cycle's starting point and consists of specific bindings between anti-receptors (or virus-attachment proteins) and cellular receptors molecules such as (glyco)proteins. The host range of a virus is determined by the specificity of the binding. The attachment causes the viral protein to change its configuration and thus fuse with the host's cell membrane; thereby enabling the virus to enter the cell.[6]

Penetration of virus happens either through membrane fusion or receptor-mediated endocytosis and leads to viral entry. Due to their rigid cellulose-made

(chitin in case of fungal cells) cell walls, plants and fungal cells get infected differently than animal cells. Often, a cell wall trauma is required for the virus to enter the cell.[6]

Uncoating is the removal of viral capsid, which makes the viral nucleic acids available for transcription. The capsid could have been degraded by either host or viral enzymes, releasing the viral genome into the cell.[6]

Replication is the multiplication of virus's genetic material. The process includes the transcription of mRNA, synthesis, and assembly of viral proteins and is regulated by protein expression.[6]

Assembly process involves putting together and modifying newly-made viral nucleic acids and structural proteins to form the virus's nucleocapsid.[2][7]

Release of viruses could be done by two different mechanisms depending on the type of virus. Lytic viruses burst the cell's membrane or wall through a process called lysis in order to release themselves. On the other hand, enveloped viruses become released by a process called budding in which a viruse obtain its lipid membrane as it buds out of the cell through membrane or intracellular vesicle. Both lysis and budding processes are highly damaging to the cell, with the exception of retroviruses, and often result in the cell's death.[2][6]

Viral pathogenesis

Pathogenicity is the ability of one organism to cause disease in another. There is a specialized field of study in virology called viral pathogenesis in which it studies how viruses infect their hosts at the molecular and cellular level.[2]

In order for the viral disease to develop several steps need to be taken. First, the virus has to enter the body and implant itself into a tissue ( e.g. respiratory tissue). Second, the virus has to reproduce extracellular after invading in order to make ample copies of itself. Third, the synthesized viruses must spread throughout the body via circulatory systems or nerve cells.[8]

Respiratory syncytial virus (RSV) infection usually produces widespread bronchiolitis and interstitial pneumonia which may sometimes by associated with giant cells. This image shows a non-specific interstitial pneumonia pattern with no giant cells present.

With regards to viral diseases it is essential to look at two aspects: (a) the direct effect of virus replication; (b) the body’s responses to infection. The course and severity of all viral infections are determined by the dynamic between the virus and the host. Common symptoms of virus infections are fever, body aches, inflammation, and skin rashes. Most of these symptoms are caused by our immune system’s response to infection and are not the direct effect of viral replication.[2]

Cytopathis effects of virus

Often it is possible to recognize virus-infected cells through a number of common phenotypic changes referred to as cytopathis effects. These changes include:[2]

Viral infections

There are five different types of viral infections:[2]

Ebola virus virion. Created by GC microbiologist Cynthia Goldsmith, this colorized transmission electron micrograph (TEM) revealed some of the ultrastructural morphology displayed by an Ebola virus virion.

Prevention and treatment

Viral vaccines contain inactivated viruses which have lost their ability to replicate. These vaccines can prevent or lower the intensity of viral illness. Developing vaccines against smallpox, polio, and hepatitis B over the past 50 years has had a significant impact on world health and thus on global population. Nevertheless, there have been ongoing viral outbreaks ( such as the Ebola and Zika viruses) in the past few years affecting millions of people all around the globe.[9] Therefore, more advanced understanding of molecular virology and viruses are needed for the development of new vaccines and the control of ongoing/future viral outbreaks.[2]

An alternative way to treat viral infections would be antiviral drugs in which the drug blocks the virus's replication cycle. The specificity of an antiviral drug is the key to its success. These drugs are toxic to both the virus and the host but in order to minimize their damage they are developed in such a way as to be more toxic to the virus than to the host. The efficiency of an antiviral drug is measured by the chemotherapeutic index, given by:[2]

\frac{\hbox{Dose of drug that inhibits virus replication}}{\hbox{Dose of drug that is toxic to host}}
The higher the drug's efficiency , the smaller the value of chemotherapeutic index. In clinical practice, this index is used to produce a safe and clinically useful drug.[2]

References

  1. Crawford, Dorothy (2011). Viruses: A Very Short Introduction. New york, NY: Oxford University Press. pp. 4–7. ISBN 0199574855.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Cann, Alan (2012). Principles of Molecular Virology. ELSEVIER. p. 214. ISBN 9780123849403.
  3. Koonin, Eugene V.; Senkevich, Tatiana G.; Dolja, Valerian V. (2006-01-01). "The ancient Virus World and evolution of cells". Biology Direct 1: 29. doi:10.1186/1745-6150-1-29. ISSN 1745-6150. PMC 1594570. PMID 16984643.
  4. Dimmock, Nigel (2007). Introduction to Modern Virology. Wiley-Blackwell. ISBN 978-1-119-97810-7.
  5. Collier, Leslie; Balows, Albert; Sussman, Max (1998) Topley and Wilson's Microbiology and Microbial Infections ninth edition, Volume 1, Virology, volume editors: Mahy, Brian and Collier, Leslie. Arnold. ISBN 0-340-66316-2.
  6. 1 2 3 4 5 Dimmock, N.J; Easton, Andrew J; Leppard, Keith (2007) Introduction to Modern Virology sixth edition, Blackwell Publishing, ISBN 1-4051-3645-6.
  7. Barman S, Ali A, Hui EK, Adhikary L, Nayak DP. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res.. 2001;77(1):61–9. doi: 10.1016/S0168-1702(01)00266-0 .PMID 11451488
  8. Baron, S (1996). Medical Microbiology Chapter 45 Viral Pathogenesis. Galveston (TX).
  9. "2014 Ebola Virus Disease Outbreak in West Africa". WHO. 21 April 2014.

Additional links

This article is issued from Wikipedia - version of the Tuesday, April 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.